CDKN1A and central nervous system neoplasm: Because of the high prevalence of CNS tumors in Brazil (18.3%), and continuing the previous work15 that detected the presence of CDKN1A gene polymorphisms through sequencing, the goal of this study was to determine the prevalence of CDKN1A gene polymorphisms in CNS tumor patients and control individuals.